Your browser doesn't support javascript.
loading
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
Cascone, Tina; Sepesi, Boris; Lin, Heather Y; Kalhor, Neda; Parra, Edwin R; Jiang, Mei; Godoy, Myrna C B; Zhang, Jianjun; Fossella, Frank V; Tsao, Anne S; Lam, Vincent K; Lu, Charles; Mott, Frank E; Simon, George R; Antonoff, Mara B; Mehran, Reza J; Rice, David C; Behrens, Carmen; Weissferdt, Annikka; Moran, Cesar; Vaporciyan, Ara A; Lee, J Jack; Swisher, Stephen G; Gibbons, Don L; Wistuba, Ignacio I; William, William N; Heymach, John V.
Affiliation
  • Cascone T; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sepesi B; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kalhor N; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Godoy MCB; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fossella FV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsao AS; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lam VK; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lu C; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mott FE; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Simon GR; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Antonoff MB; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mehran RJ; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rice DC; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Behrens C; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weissferdt A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Moran C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vaporciyan AA; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Swisher SG; Department of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gibbons DL; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • William WN; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. jheymach@mdanderson.org William.William@bp.org.br.
  • Heymach JV; Oncology Center, Hospital BP, a Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Clin Cancer Res ; 26(14): 3525-3536, 2020 07 15.
Article in En | MEDLINE | ID: mdl-32193228

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Type: Article